American Cancer Society. Cancer Facts & Figures 2013. Atlanta, Ga; 2013.
Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20004-2008. Central Brain Tumor Registry of the United States; 2012. Accessed at www.cbtrus.org/2012-NPCR-SEER/CBTRUS_Report_2004-2008_3-23-2012.pdf on July 11, 2012.
Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012. Accessed on July 11, 2012.
Maity A, Pruitt AA, Judy KD, et al. Cancer of the central nervous system. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:1075–1136.
Mehta MP, Vogelbaum M, Chang S, Patel N. Neoplasms of the central nervous system. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:1700–1749.
National Cancer Institute Physician Data Query (PDQ). Adult Brain Tumors Treatment. 2012. Accessed at www.cancer.gov/cancertopics/pdq/treatment/adultbrain/healthprofessional on July 19, 2012.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers. V.2.2012. Accessed at www.nccn.org/professionals/physician_gls/pdf/cns.pdf on July 17, 2012.
Prados MD. Primary neoplasms of the central nervous system in adults. In: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E, eds. Cancer Medicine 7. Hamilton, Ontario: BC Decker; 2006:1037–1064.
Sampson JH, Heimberger AB, Archer GE, et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol. 2010;28:4722−4729.
Last Medical Review: 10/09/2012
Last Revised: 02/06/2013